Identification of Resistance Determinants for a Promising Antileishmanial Oxaborole Series.
Ontology highlight
ABSTRACT: Current treatment options for visceral leishmaniasis have several drawbacks, and clinicians are confronted with an increasing number of treatment failures. To overcome this, the Drugs for Neglected Diseases initiative (DNDi) has invested in the development of novel antileishmanial leads, including a very promising class of oxaboroles. The mode of action/resistance of this series to Leishmania is still unknown and may be important for its further development and implementation. Repeated in vivo drug exposure and an in vitro selection procedure on both extracellular promastigote and intracellular amastigote stages were both unable to select for resistance. The use of specific inhibitors for ABC-transporters could not demonstrate the putative involvement of efflux pumps.
SUBMITTER: Van den Kerkhof M
PROVIDER: S-EPMC8305145 | biostudies-literature | 2021 Jun
REPOSITORIES: biostudies-literature
ACCESS DATA